keyword
https://read.qxmd.com/read/38635933/genomic-landscape-of-circulating-tumor-dna-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-metastatic-breast-cancer-treated-with-abemaciclib-data-from-the-scrum-japan-cancer-genome-screening-project
#1
JOURNAL ARTICLE
Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwata
PURPOSE: To understand the mutational landscape of circulating tumor DNA (ctDNA) and tumor tissue of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (MBC) treated with abemaciclib + endocrine therapy (ET). METHODS: Blood samples for ctDNA and/or tissue samples were collected from abemaciclib-treated patients with HR+/HER2- MBC enrolled in the SCRUM-Japan MONSTAR-SCREEN project. Blood samples were collected before abemaciclib initiation (baseline) and at disease progression/abemaciclib discontinuation (post abemaciclib treatment)...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38635895/fc-silent-anti-tigit-antibodies-potentiate-anti-tumor-immunity-without-depleting-regulatory-t-cells
#2
JOURNAL ARTICLE
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P Walker, Matthew J Walters, Kelsey E Sivick
TIGIT is an inhibitory receptor on immune cells that outcompetes an activating receptor, CD226, for shared ligands. Tumor-infiltrating lymphocytes express TIGIT and CD226 on regulatory T cells (Treg) and on CD8+ T cells with tumor-reactive or exhausted phenotypes, supporting the potential of therapeutically targeting TIGIT to enhance anti-tumor immunity. To optimize the efficacy of therapeutic antibodies against TIGIT, it is necessary to understand whether there is therapeutic benefit from Fcγ receptor (FcγR) binding...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635586/a-predictive-non-invasive-snp-based-biomarker-signature-in-resectable-pancreatic-cancer-protocol-for-a-prospective-validation-study
#3
JOURNAL ARTICLE
Nico Seeger, Stefan Gutknecht, Irin Zschokke, Isabella Fleischmann, Nadja Roth, Jürg Metzger, Markus Weber, Stefan Breitenstein, Lukasz Filip Grochola
BACKGROUND: Single nucleotide polymorphisms (SNPs) are inherited genetic variants that can be easily determined in everyday clinical practice using a simple blood or even saliva test. They have the potential to serve as non-invasive biomarkers to predict cancer-specific patient outcomes after resection of pancreatic ductal adenocarcinoma (PDAC). Specifically, two recent analyses led to the identification and validation of three SNPs in the CD44 and CHI3L2 genes (SNPrs187115, SNPrs353630, SNPrs684559) that can be utilised as predictive biomarkers to help select patients who are likely to benefit from pancreatic resection...
April 2, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38635559/pistacia-lentiscus-l-revealed-in-vitro-anti-proliferative-activity-on-mcf-7-breast-cancer-cells-and-in-vivo-anti-mammary-cancer-effect-on-c57bl-6-mice-through-necrosis-anti-inflammatory-and-antioxidant-enhancements
#4
JOURNAL ARTICLE
Omayma Abidi, Zaineb Abdelkafi-Koubaa, Ilhem Bettaieb-Dridi, Lamjed Toumi, Lamjed Marzouki, Ouajdi Souilem
Inflammation and oxidative stress are two interconnected processes that play a role in cancer development and progression. In the present research, we aimed to evaluate the anticancer effect of Pistacia lentiscus L. (PL) essential oil (EO) in vitro against MCF-7 breast cancer cells and in vivo in DMBA-mammary cancer induction on female C57BL/6 mice model as well as to investigate its anti-inflammatory and antioxidant potential as implicated mechanism. Our results revealed a new chemotypes-profile of 39 bio-compounds of PL EO...
2024: PloS One
https://read.qxmd.com/read/38635542/from-code-to-care-clinician-and-researcher-perspectives-on-an-optimal-therapeutic-web-portal-for-acute-myeloid-leukemia
#5
JOURNAL ARTICLE
Terese Knoppers, Cassandra E Haley, Sarah Bouhouita-Guermech, Julie Hagan, Jacqueline Bradbury-Jost, Samuel Alarie, Marie Cosquer, Ma'n H Zawati
BACKGROUND: Acute myeloid leukemia (AML), a rapidly progressing cancer of the blood and bone marrow, is the most common and fatal type of adult leukemia. Therapeutic web portals have great potential to facilitate AML research advances and improve health outcomes by increasing the availability of data, the speed and reach of new knowledge, and the communication between researchers and clinicians in the field. However, there is a need for stakeholder research regarding their optimal features, utility, and implementation...
2024: PloS One
https://read.qxmd.com/read/38635241/development-and-validation-of-an-18-gene-urine-test-for-high-grade-prostate-cancer
#6
JOURNAL ARTICLE
Jeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L Samora, Yashar S Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, Hunter S Robinson, Kumaran Arivoli, Bruce J Trock, Ashley E Ross, Todd M Morgan, Ganesh S Palapattu, Simpa S Salami, Lakshmi P Kunju, Scott A Tomlins, Lori J Sokoll, Daniel W Chan, Sudhir Srivastava, Ziding Feng, Martin G Sanda, Yingye Zheng, John T Wei, Arul M Chinnaiyan
IMPORTANCE: Benefits of prostate cancer (PCa) screening with prostate-specific antigen (PSA) alone are largely offset by excess negative biopsies and overdetection of indolent cancers resulting from the poor specificity of PSA for high-grade PCa (ie, grade group [GG] 2 or greater). OBJECTIVE: To develop a multiplex urinary panel for high-grade PCa and validate its external performance relative to current guideline-endorsed biomarkers. DESIGN, SETTING, AND PARTICIPANTS: RNA sequencing analysis of 58 724 genes identified 54 markers of PCa, including 17 markers uniquely overexpressed by high-grade cancers...
April 18, 2024: JAMA Oncology
https://read.qxmd.com/read/38635119/design-and-navigation-method-of-a-soft-robot-for-single-port-transvesical-radical-prostatectomy
#7
JOURNAL ARTICLE
Zefeng Liu, Ru Li, Yongfeng Cao, Le Xie
PURPOSE: Currently, the rigid instruments used for laparoscopic radical resection of prostate cancer not only have the risk of damage to tissues, blood vessels, and nerves, but their limited freedom will also cause surgical blind areas. Soft robots are expected to solve these issues due to inherent flexibility, compliance, and safe interaction with tissues and organs. In addition, to achieve high surgical accuracy and provide precise guidance for surgeons, the navigation method should be studied for the soft robot...
April 18, 2024: International Journal of Computer Assisted Radiology and Surgery
https://read.qxmd.com/read/38635100/associations-between-mitochondrial-copy-number-exercise-capacity-physiologic-cost-of-walking-and-cardiac-strain-in-young-adult-survivors-of-childhood-cancer
#8
JOURNAL ARTICLE
Amy M Berkman, Chelsea G Goodenough, Paul Durakiewicz, Carrie R Howell, Zhaoming Wang, John Easton, Heather L Mulder, Gregory T Armstrong, Melissa M Hudson, Mondira Kundu, Kirsten K Ness
PURPOSE: Childhood cancer survivors are at risk for cardiac dysfunction and impaired physical performance, though underlying cellular mechanisms are not well studied. In this cross-sectional study, we examined the association between peripheral blood mitochondrial DNA copy number (mtDNA-CN, a proxy for mitochondrial function) and markers of performance impairment and cardiac dysfunction. METHODS: Whole-genome sequencing, validated by quantitative polymerase chain reaction, was used to estimate mtDNA-CN in 1720 adult survivors of childhood cancer (48...
April 18, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38634790/blood-based-multiomics-guided-detection-of-a-precancerous-pancreatic-tumor
#9
JOURNAL ARTICLE
Mohammad A Anwar, Ammar H Keshteli, Haiyan Yang, Windy Wang, Xukun Li, Helen M Messier, Pieter R Cullis, Christoph H Borchers, Robert Fraser, David S Wishart
Over a decade ago, longitudinal multiomics analysis was pioneered for early disease detection and individually tailored precision health interventions. However, high sample processing costs, expansive multiomics measurements along with complex data analysis have made this approach to precision/personalized medicine impractical. Here we describe in a case report, a more practical approach that uses fewer measurements, annual sampling, and faster decision making. We also show how this approach offers promise to detect an exceedingly rare and potentially fatal condition before it fully manifests...
April 17, 2024: Omics: a Journal of Integrative Biology
https://read.qxmd.com/read/38634292/hypertension-severity-and-declines-in-left-ventricular-ejection-fraction-among-women-receiving-adjuvant-chemotherapy-for-breast-cancer-wf-97415-upbeat
#10
JOURNAL ARTICLE
Riya Garg, Ralph B D'Agostino, Nathaniel O'Connell, Glenn J Lesser, Fadi N Salloum, Anika L Hines, Giselle C Meléndez, Jennifer H Jordan, Bonnie Ky, Lynne I Wagner, Arnethea L Sutton, Wendy Bottinor, Kristine Olson, Amy C Ladd, W Gregory Hundley
BACKGROUND: Hypertension is a risk factor for experiencing left ventricular ejection fraction (LVEF) declines during receipt of potentially cardiotoxic breast cancer (BC) treatment. We sought to determine whether the hypertension stage is associated with LVEF decline during BC treatment. METHODS: Across 24 centers, cardiac magnetic resonance measures of LVEF and brachial arterial blood pressure (BP) measurements were performed in women with stages I to III BC before and 3 months after initiating potentially cardiotoxic chemotherapy...
April 18, 2024: Hypertension
https://read.qxmd.com/read/38633837/computational-and-experimental-microfluidics-total-analysis-system-for-mixing-sorting-and-concentrating-particles-and-cells
#11
JOURNAL ARTICLE
David Coral, Matthew Attard, Eric Pedrol, Rosa Maria Solé, Francesc Díaz, Magdalena Aguiló, Xavier Mateos
Body fluids can potentially indicate the presence of non-small cancer cells. Studying these fluids is an emerging field that could be crucial for cancer detection and monitoring treatment effectiveness. Meanwhile, the examination of fluids on a microscopic level is part of the field of microfluidics. This study focuses on the development of a total analysis system that consists of various interconnected structures that are designed to mix, classify, concentrate, and isolate particles in fluids that mimic the behavior of cancer and normal cells...
June 2024: APL Bioengineering
https://read.qxmd.com/read/38633829/the-impact-of-pre-biopsy-mri-and-additional-testing-on-prostate-cancer-screening-outcomes-a-rapid-review
#12
REVIEW
Abel Tesfai, Natalia Norori, Thomas A Harding, Yui Hang Wong, Matthew David Hobbs
OBJECTIVE: This work aims to examine the latest evidence on the impact of pre-biopsy MRI, in addition to prostate-specific antigen (PSA) testing, on health outcomes and quality of life. METHODS: We conducted a literature search including PubMed and Cochrane Central Register of Controlled Trials (CENTRAL) databases, with a limited scan of (i) guidelines and (ii) references from trial reports, from January 2005 to 25th January 2023. Two independent reviewers selected randomised controlled trials (RCT) and cohort studies which met our inclusion criteria...
April 2024: BJUI compass
https://read.qxmd.com/read/38633688/symptoms-electrolyte-disturbances-and-serum-albumin-levels-in-palliative-oncology-patients-admitted-through-emergency-characteristics-and-survival-outcomes
#13
JOURNAL ARTICLE
Mahesh Menon, Subhashini Perumal, Raza Ahmad, Priya Das, Shiv Pratap Singh Rana, Asif Sardar
OBJECTIVES: Our research aimed to examine the characteristics of palliative oncology patients hospitalised through an emergency to look for the symptom profile, characteristics of dyselectrolytemia and blood investigations, and possible associations with mortality. MATERIALS AND METHODS: After institutional review board approval, a retrospective, observational study of patients hospitalised in our tertiary care specialty oncology hospital was undertaken. Records of hospitalised cancer patients admitted from the emergency department under palliative care from January 2019 to October 2021 were examined...
2024: Indian Journal of Palliative Care
https://read.qxmd.com/read/38632641/effect-of-preoperative-immunonutrition-on-postoperative-short-term-clinical-outcomes-in-patients-with-gastric-cancer-cachexia-a-prospective-randomized-controlled-trial
#14
JOURNAL ARTICLE
Junjian Yu, Antai Yuan, Qi Liu, Wei Wang, Yuqi Sun, Zequn Li, Cheng Meng, Yanbing Zhou, Shougen Cao
BACKGROUND: Although current guidelines(ESPEN guideline: Clinical nutrition in surgery and other guidelines) recommend preoperative immunonutrition for cachectic gastric cancer patients, the strength of the recommendation is weak, and the level of evidence is low. The benefits of preoperative immunonutrition still remain controversial. PATIENTS AND METHODS: 112 patients with gastric cancer cachexia were enrolled in the study and randomly assigned in a 1:1 ratio to receive either preoperative enteral immunonutrition support (IN, n = 56) or standard enteral nutrition support (SEN, n = 56)...
April 17, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38632501/phase-i-ii-clinical-trial-of-efficacy-and-safety-of-egcg-oxygen-nebulization-inhalation-in-the-treatment-of-covid-19-pneumonia-patients-with-cancer
#15
JOURNAL ARTICLE
Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, Guangjian Yang, Xianguang Zhao, Kaikai Zhao, Liyang Jiang, Xiaolin Li, Hong Zhao, Xin Wang, Yuanyuan Yan, Ligang Xing, Jinming Yu, Xiangjiao Meng, Hanxi Zhao
BACKGROUND: The antiviral drug Nirmatrelvir was found to be a key drug in controlling the progression of pneumonia during the infectious phase of COVID-19. However, there are very few options for effective treatment for cancer patients who have viral pneumonia. Glucocorticoids is one of the effective means to control pneumonia, but there are many adverse events. EGCG is a natural low toxic compound with anti-inflammatory function. Thus, this study was designed to investigate the safety and efficacy of epigallocatechin-3-gallate (EGCG) aerosol to control COVID-19 pneumonia in cancer populations...
April 17, 2024: BMC Cancer
https://read.qxmd.com/read/38632333/a-multi-cancer-early-detection-blood-test-using-machine-learning-detects-early-stage-cancers-lacking-uspstf-recommended-screening
#16
JOURNAL ARTICLE
Janet Vittone, David Gill, Alex Goldsmith, Eric A Klein, Jordan J Karlitz
US Preventive Services Task Force (USPSTF) guidelines recommend single-cancer screening for select cancers (e.g., breast, cervical, colorectal, lung). Advances in genome sequencing and machine learning have facilitated the development of blood-based multi-cancer early detection (MCED) tests intended to complement single-cancer screening. MCED tests can interrogate circulating cell-free DNA to detect a shared cancer signal across multiple tumor types. We report real-world experience with an MCED test that detected cancer signals in three individuals subsequently diagnosed with cancers of the ovary, kidney, and head/neck that lack USPSTF-recommended screening...
April 17, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38632250/molecular-detection-of-exosomal-mirnas-of-blood-serum-for-prognosis-of-colorectal-cancer
#17
JOURNAL ARTICLE
Tahani Bakhsh, Safiah Alhazmi, Ali Farsi, Abdulaziz S Yusuf, Amani Alharthi, Safa H Qahl, Maha Ali Alghamdi, Faisal A Alzahrani, Ola H Elgaddar, Mohanad A Ibrahim, Ahmed Bahieldin
Colorectal cancer (CRC) is the third most common cancer affecting people. The discovery of new, non-invasive, specific, and sensitive molecular biomarkers for CRC may assist in the diagnosis and support therapeutic decision making. Exosomal miRNAs have been demonstrated in carcinogenesis and CRC development, which makes these miRNAs strong biomarkers for CRC. Deep sequencing allows a robust high-throughput informatics investigation of the types and abundance of exosomal miRNAs. Thus, exosomal miRNAs can be efficiently examined as diagnostic biomarkers for disease screening...
April 17, 2024: Scientific Reports
https://read.qxmd.com/read/38632186/pharmacokinetic-interaction-between-regorafenib-and-atorvastatin-in-rats
#18
JOURNAL ARTICLE
Danuta Szkutnik-Fiedler, Edyta Szałek, Filip Otto, Andrzej Czyrski, Marta Karaźniewicz-Łada, Anna Wolc, Edmund Grześkowiak, Konrad Lewandowski, Agnieszka Karbownik
BACKGROUND: Regorafenib is used in the treatment of colorectal cancer and hepatocellular carcinoma. Due to the co-morbidity of hyperlipidemia in these conditions, statins, including atorvastatin, are used as potential adjuvant therapy agents. Both regorafenib and atorvastatin are metabolized by CYP3A4. In addition, atorvastatin is a P-gp and BCRP substrate, whereas regorafenib and its active metabolites M-2 and M-5 are inhibitors of these transporters. Hence, the concomitant use of both drugs may increase the risk of a clinically significant drug-drug interaction...
April 18, 2024: Pharmacological Reports: PR
https://read.qxmd.com/read/38631967/open-versus-minimally-invasive-nephroureterectomy-in-octogenarians-an-analysis-of-surgical-approach-trends-outcomes-and-survival-analysis-with-propensity-matching
#19
JOURNAL ARTICLE
Shaun Trecarten, Mukund Bhandari, Ahmad Abdelaziz, Onika Noel, Michael Liss, Furkan Dursun, Robert Svatek, Ahmed M Mansour
INTRODUCTION: Upper tract urothelial carcinoma (UTUC) is a rare disease accounting only for 5%-10% of urothelial carcinoma (UC). For localized high-risk disease, radical nephroureterectomy (RNU) is the standard of care. While minimally invasive (MIS) RNU has not been shown to decisively improve overall survival (OS) compared to open surgery, MIS RNU has been associated with reduced hospital length of stay (LOS), blood transfusion requirements and improved recovery, which are important considerations when treating older patients...
April 16, 2024: Urologic Oncology
https://read.qxmd.com/read/38631956/identifying-major-histocompatibility-complex-class-ii-dr-molecules-in-bovine-and-swine-peripheral-blood-monocyte-derived-macrophages-using-mab-l243
#20
JOURNAL ARTICLE
Carmen Celis-Giraldo, Diego Ordoñez, Diana Díaz-Arévalo, Michel D Bohórquez, Nieves Ibarrola, Carlos F Suárez, Kewin Rodríguez, Yoelis Yepes, Alexander Rodríguez, Catalina Avendaño, Julio López-Abán, Raúl Manzano-Román, Manuel Alfonso Patarroyo
Major histocompatibility complex class II (MHC-II) molecules are involved in immune responses against pathogens and vaccine candidates' immunogenicity. Immunopeptidomics for identifying cancer and infection-related antigens and epitopes have benefited from advances in immunopurification methods and mass spectrometry analysis. The mouse anti-MHC-II-DR monoclonal antibody L243 (mAb-L243) has been effective in recognising MHC-II-DR in both human and non-human primates. It has also been shown to cross-react with other animal species, although it has not been tested in livestock...
April 16, 2024: Vaccine
keyword
keyword
162637
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.